R. Andre Bell (301) 734-3853
Lyndsay Cole (970) 494-7410
Environmental Assessment on Genetically Engineered Eucalyptus
WASHINGTON, Feb. 10, 2012—The U.S. Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS) today announced that it has prepared an environmental assessment (EA) for a proposed controlled field release of a genetically engineered clone of a Eucalyptus hybrid.
On February 21, 2011, APHIS received a permit application from ArborGen, LLC for a controlled field release of genetically engineered Eucalyptus hybrids in six locations across the United States. The purpose of the field release is to assess the effectiveness of gene constructs intended to confer cold tolerance, to test the efficacy of genes introduced to alter lignin biosynthesis, to test the efficacy of genes designed to alter growth, and to test the efficacy of genes designed to alter flowering.
APHIS is making its EA available for public comment. APHIS has prepared its EA to consider the potential environmental effects of a release under permit, consistent with the Council on Environmental Quality's regulations implementing the National Environmental Policy Act regulations and procedures. This EA has been prepared in order to specifically evaluate the effects on the quality of the human environment that may result from a release under permit of genetically engineered Eucalyptus.
The notice of availability of the EA is published in today's Feb. 10 Federal Register.
Consideration will be given to comments received on or before March 12. You may submit comments by either of the following methods:
Note to Reporters: USDA news releases, program announcements and media advisories are available on the Internet and through Really Simple Syndication (RSS) feeds. Go to the APHIS news release page at www.aphis.usda.gov/newsroom and click on the RSS feed link.
USDA is an equal opportunity provider, employer and lender. To file a complaint of discrimination, write:
USDA, Director, Office of Civil Rights, 1400 Independence Ave., SW., Washington, DC 20250-9410 or call
(800) 795-3272 or (202) 720-6382 (TDD).